A Population-Based Cohort Study of Undervaccination in 8 Managed Care Organizations Across the United States
Jason M. Glanz(Kaiser Permanente), Eric Weintraub, Matthew F. Daley(Kaiser Permanente), David L. McClure(Marshfield Clinic), James G. Donahue(Brigham and Women's Hospital), Jennifer C. Nelson(Kaiser Permanente Washington Health Research Institute), Grace M. Lee, Nicole Wägner(Kaiser Permanente), Ali Rowhani‐Rahbar(University of Washington), James D. Nordin(HealthPartners), Sophia R. Newcomer(University of Montana), Marlene M. Lugg(Kaiser Permanente), Komal J. Narwaney(Kaiser Permanente), Simon J. Hambidge, Stan Xu, Allison L. Naleway(Centers for Disease Control and Prevention)
Cited by 169
Related Papers
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Human Papillomavirus Vaccination Practices: A Survey of US Physicians 18 Months After Licensure
|PEDIATRICS|2010|242
Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
|Vaccine|2011|228
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021
|MMWR Morbidity and Mortality Weekly Report|2021|216